Researchers report difficulties retaining staff as White House cost-cutting stresses US medical research system
Major Alzheimer’s disease research centers across the country face a $65m funding gap amid a Trump administration-imposed delay, with at least one struggling to retain highly trained staff.
Although courts have ruled a government-wide funding freeze is illegal, the administration has managed to delay research funding by canceling scientific meetings and failing to publish forthcoming meetings in the Federal Register, both which are legally required.
More Stories
The latest twist in a Canadian medical mystery – podcast
‘E-tattoo’ could track mental workload for people in high-stake jobs, study says
Elon Musk shows he still has the White House’s ear on Trump’s Middle East trip